SPRB
SPRUCE BIOSCIENCES, INC.
-0.07 (-0.13%)54.09USD88.5K成交股數155M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 0.00-100% | 0.00-100% | 0.00-100% | 0.00-100% | 602K-80% | 1.6M-26% | 2.0M | 2.9M | 3.1M | 2.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 12.2M | 7.6M | 4.1M | 5.0M | −430K | 10.8M | 6.6M | 8.1M | 10.3M | 11.1M | 13.5M | 13.1M |
| 銷售管理費用 | 4.3M | 4.4M | 7.0M | 3.2M | 3.1M | 3.7M | 3.5M | 3.6M | 4.3M | 3.0M | 3.2M | 3.0M |
| 營業利益 | −16.5M+513% | −12.0M-17% | −11.1M+18% | −8.2M-18% | −2.7M-79% | −14.5M+30% | −9.4M-31% | −10.0M-28% | −12.6M | −11.2M | −13.7M | −14.0M |
| 營業利益率 | – | – | – | – | – | – | -1,562.8% | -623.4% | -631.0% | -386.7% | -444.5% | -645.4% |
| 稅後淨利 | −16.2M+685% | −12.3M-13% | −14.6M+69% | −8.2M-11% | −2.1M-82% | −14.0M+41% | −8.7M-30% | −9.2M-28% | −11.6M | −10.0M | −12.4M | −12.8M |
| 淨利率 | – | – | – | – | – | – | -1,440.4% | -570.2% | -580.7% | -344.6% | -402.0% | -592.3% |
| 稀釋 EPS | -6.68+91% | -8.94-63% | -8.80-44% | -14.58-13% | -3.50+1150% | -23.95+10786% | -15.75+5150% | -16.73+5128% | -0.28 | -0.22 | -0.30 | -0.32 |
| 稀釋股數 | 2.4M | 1.4M | 767K | 563K | 591K | 586K | 551K | 549K | 41.1M | 38.5M | 40.7M | 40.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 96.3M | 54.1M | 48.9M | 10.7M | 16.4M | 25.6M | 60.1M | 69.7M | 81.2M | 96.3M | 98.8M | 97.5M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 103M | 56.2M | 53.0M | 15.3M | 21.8M | 31.6M | 65.1M | 75.5M | 87.5M | 104M | 113M | 126M |
| 有息負債 | 4.6M | 5.5M | 0.00 | 0.00 | 0.00 | 0.00 | 524K | 923K | 1.3M | 1.7M | 2.1M | 2.5M |
| 總負債 | 19.1M | 21.5M | 10.5M | 9.9M | 8.6M | 16.3M | 13.5M | 16.4M | 20.9M | 27.4M | 27.6M | 29.4M |
| 股東權益 | 83.7M | 34.6M | 42.5M | 5.4M | 13.2M | 15.3M | 51.6M | 59.2M | 66.6M | 76.5M | 85.4M | 96.6M |
| 負債比 | 18.6% | 38.3% | 19.8% | 64.8% | 39.6% | 51.6% | 20.7% | 21.7% | 23.9% | 26.4% | 24.4% | 23.3% |
| 淨現金(現金 − 有息負債) | 91.7M | 48.6M | 48.9M | 10.7M | 16.4M | 25.6M | 59.5M | 68.8M | 79.8M | 94.6M | 96.7M | 95.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.7M-31% | – | – | – | −12.7M | – | – | −15.0M | – | – | – |
| 資本支出 | – | 10K | – | – | – | 0.00 | – | – | – | – | – | – |
| 自由現金流 | – | −8.7M-31% | – | – | – | −12.7M | – | – | – | – | – | – |
| 折舊攤銷 | – | 252K | – | – | – | 6K | – | – | 15K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | -100.0% | −39.0M | –% | -50.83 | – |
| FY2024 | 4.9M | -51.3% | −53.0M | -1,079.9% | -96.40 | −56.0M |
| FY2023 | 10.1M | – | −47.9M | -475.0% | -1.24 | −33.3M |
| FY2022 | 0.00 | – | −46.2M | –% | -1.96 | −41.7M |
| FY2021 | – | – | −42.3M | –% | -1.81 | −36.0M |
| FY2020 | – | – | −29.5M | –% | -4.93 | −27.6M |
| FY2019 | – | – | −13.1M | –% | -17.12 | −12.6M |